Search

everythinglearnresearchcommunity

for

Search:↓

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Balancing testosterone may reduce COVID-19 severity.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Targeting TRP channels may help reduce excessive scarring.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Taohong Siwu Decoction may help treat hair loss by targeting multiple genes and pathways.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Ancient immune and signaling pathways still regulate blood cell development.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Tiny particles from brain cells help hair grow by targeting a specific hair growth pathway.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Natural ingredients may help reduce skin aging by protecting cells and boosting collagen.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.